Kitov Pharmaceuticals Holdings Ltd (KTOV) Trading Down 3.5%
Shares of Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) were down 3.5% on Tuesday . The company traded as low as $3.06 and last traded at $3.07, with a volume of 79,142 shares. The stock had previously closed at $3.18.
A number of analysts have weighed in on KTOV shares. Rodman & Renshaw reissued a “buy” rating on shares of Kitov Pharmaceuticals Holdings in a report on Saturday, May 14th. Zacks Investment Research upgraded shares of Kitov Pharmaceuticals Holdings from a “hold” rating to a “buy” rating and set a $6.25 target price on the stock in a research report on Wednesday, April 27th.
The firm’s market cap is $11.98 million. The stock has a 50-day moving average price of $3.10 and a 200 day moving average price of $3.99.
Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.